Clinical Use of DPP-4 Inhibitors | Semantic Scholar
Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation | Scientific Reports
Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune Myocarditis | JACC: Basic to Translational Science
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism - Natasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill, 2020
Role of DPP-4 Inhibitors in Clinical Practice
Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2 - ScienceDirect
Frontiers | Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
Dipeptidyl peptidase-4 inhibitor - Wikipedia
Dipeptidyl peptidase IV (DPP4) Inhibitor Screening Assay Kit (ab133081) | Abcam
Antioxidants | Free Full-Text | Renoprotective Effects of DPP-4 Inhibitors
DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment | Hypertension
IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect
PDB-101: Global Health: Diabetes Mellitus: Drugs: DPP4 inhibitor: DPP4
Glucagon.com
Molecules | Free Full-Text | Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
The regulatory role of DPP4 in atherosclerotic disease | Cardiovascular Diabetology | Full Text
DPP-4 Inhibitors
DPP-4 INHIBITORS - Dipeptidyl peptidase-4 inhibitor - Gliptins - GlobalRPH
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes - ScienceDirect
Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
DPP4 in Cardiometabolic Disease | Circulation Research
Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications | JACC: Heart Failure
DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2–COX-2–TP Axis and NLRP3 Inflammasome Activation | Hypertension
